The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study

Background: A less effective nomogram for patients with intermediate-stage hepatocellular carcinoma (HCC) to predict overall survival (OS) is available. This study aimed to investigate the role of age-male-albumin-bilirubin-platelet (aMAP) scores in the prognosis of patients with intermediate-stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yaying, Shi, Yanhong, Lu, Linbin, Wang, Xuewen, Lin, Qin, Lin, Yihong, Wang, Ruiqi, Zhu, Hongwu, Zheng, Peichan, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240665/
https://www.ncbi.nlm.nih.gov/pubmed/37283795
http://dx.doi.org/10.7150/jca.79377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240665/
https://www.ncbi.nlm.nih.gov/pubmed/37283795
http://dx.doi.org/10.7150/jca.79377

Ejemplares similares